# ImageneBio, Inc. (IMA)

> Source: Nexqual · https://nexqual.com/IMA · data as of 2026-10-15 20:00 UTC · cite as "Nexqual, ImageneBio, Inc. (IMA), nexqual.com/IMA" · informational, not investment advice.

**Price:** USD 4.03 (-2.90% on the day) · last close of Oct 15, 2026; US market closed, not a live price. Prev close 4.15 · day 3.98–4.26 · 52w 3.9–9.1 · market cap $45.8M · NCM

## Key facts
- Analysts: Hold (mean 2.50 on a 1–5 scale) (4 analysts), mean target USD 18 (range 2–28).
- Total return with dividends: 1Y -46.9% vs S&P 500 +18.1%; 5Y -97.2% vs S&P 500 +85.1%.

## Analysts
Consensus Hold (mean 2.50 on a 1–5 scale), 4 analysts; mean target USD 18 (low 2, high 28).
Rating changes, last 120 days:
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| 2026-08-21 | HC Wainwright & Co. | Initiated | Buy | $28 |

## Total return (dividends reinvested)
|  | 1Y (from 2025-10-16) | 5Y (from 2021-10-11) |
|---|---|---|
| Total return | -46.9% | -97.2% |
| S&P 500 (SPY) | +18.1% | +85.1% |
| Per year | -47.0% | -51.1% |
| Volatility (annualized) | 56.7% | 95.1% |
| Max drawdown | -54.1% (Oct 2025→Oct 2026) | -98.0% (Nov 2021→Oct 2026) |

## Peers (Biotechnology)
RYTM (Rhythm Pharmaceuticals, Inc.) USD 87.97 +1.57% · BLTE (Belite Bio, Inc) USD 152.62 +0.49% · IOVA (Iovance Biotherapeutics, Inc.) USD 14.72 +1.52% · PRAX (Praxis Precision Medicines, Inc) USD 248.24 +2.01% · IONS (Ionis Pharmaceuticals, Inc.) USD 44.12 +4.11% · SYRE (Spyre Therapeutics, Inc.) USD 80.1 -0.44%

## More
Full page: https://nexqual.com/IMA · Free keyless MCP server with the same data and citations: https://mcp.nexqual.com/mcp · Guide for agents: https://nexqual.com/agents · https://nexqual.com/llms.txt